January 2024
1. TOYOFUKU T, Ishikawa T, Nojima S, Kumanogoh A, et al
   Efficacy against Lung Cancer Is Augmented by Combining Aberrantly N-Glycosylated T Cells with a Chimeric Antigen Receptor Targeting Fragile X Mental Retardation 1 Neighbor.
   J Immunol. 2024 Jan 12:ji2300618. doi: 10.4049/jimmunol.2300618.
   

   >> Share

   
   October 2023
2. RAV E, Maegawa S, Gopalakrishnan V, Gordon N, et al
   Overview of CD70 as a Potential Therapeutic Target for Osteosarcoma.
   J Immunol. 2023;211:1067-1072.
   

   >> Share

   
   June 2023
3. LIU C, Liu T, Hu Y, Zeng X, et al
   G Protein-Coupled Receptor 56 Characterizes CTLs and Reflects the Progression of Lung Cancer Patients.
   J Immunol. 2023 Jun 28:ji2101048. doi: 10.4049/jimmunol.2101048.
   

   >> Share

   
   September 2022
4. FAN TW, Daneshmandi S, Cassel TA, Uddin MB, et al
   Polarization and beta-Glucan Reprogram Immunomodulatory Metabolism in Human Macrophages and Ex Vivo in Human Lung Cancer Tissues.
   J Immunol. 2022 Sep 23. pii: jimmunol.2200178. doi: 10.4049/jimmunol.2200178.
   

   >> Share

   
   August 2022
5. YOO KJ, Johannes K, Gonzalez LE, Patel A, et al
   LIGHT (TNFSF14) Costimulation Enhances Myeloid Cell Activation and Antitumor Immunity in the Setting of PD-1/PD-L1 and TIGIT Checkpoint Blockade.
   J Immunol. 2022;209:510-525.
   

   >> Share

   
   January 2022
6. ZHENG Y, Chen Z, Zhou B, Chen S, et al
   PRMT5 Deficiency Enforces the Transcriptional and Epigenetic Programs of Klrg1(+)CD8(+) Terminal Effector T Cells and Promotes Cancer Development.
   J Immunol. 2022;208:501-513.
   

   >> Share

   
   September 2021
7. LI Z, Gao Y, He C, Wei H, et al
   Purinergic Receptor P2Y6 Is a Negative Regulator of NK Cell Maturation and Function.
   J Immunol. 2021;207:1555-1565.
   

   >> Share

   
   April 2021
8. CHEN CW, Bennion KB, Swift DA, Morrow KN, et al
   Tumor-Specific T Cells Exacerbate Mortality and Immune Dysregulation during Sepsis.
   J Immunol. 2021 Apr 28. pii: jimmunol.2000865. doi: 10.4049/jimmunol.2000865.
   

   >> Share

   
   March 2021
9. AFROJ T, Mitsuhashi A, Ogino H, Saijo A, et al
   Blockade of PD-1/PD-L1 Pathway Enhances the Antigen-Presenting Capacity of Fibrocytes.
   J Immunol. 2021;206:1204-1214.
   

   >> Share

   
   November 2020
10. YI FS, Zhang X, Zhai K, Huang ZY, et al
    TSAd Plays a Major Role in Myo9b-Mediated Suppression of Malignant Pleural Effusion by Regulating TH1/TH17 Cell Response.
    J Immunol. 2020;205:2926-2935.
    

    >> Share

    
    
11. KOHNO M, Murakami J, Wu L, Chan ML, et al
    Foxp3(+) Regulatory T Cell Depletion after Nonablative Oligofractionated Irradiation Boosts the Abscopal Effects in Murine Malignant Mesothelioma.
    J Immunol. 2020;205:2519-2531.
    

    >> Share

    
    

Free Medical Abstracts
Privacy Policy
Sponsors
Share